Palo Alto, California 94304

  • Narcolepsy

Purpose:

Nexus is a collaboration between academic institutions, advocacy and industry to answer important questions about narcolepsy. It is a web-based observational study of patient-reported outcomes in adult patients with narcolepsy, with follow-up every six months. Nexus website: www.narcolepsyregistry.com


Criteria:

Inclusion Criteria: - 18 years or older - Diagnosed with narcolepsy by a doctor


NCT ID:

NCT02769780


Primary Contact:

Study Director
Danielle Hyman, PhD
Jazz Pharmaceuticals

JeanPierre Coaquira, MPH
Phone: 650-496-3641
Email: JeanPierre.Coaquira@JazzPharma.com


Backup Contact:

N/A


Location Contact:

Palo Alto, California 94304
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: September 28, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.